Investigating the potential impact of post translational modification of auto-antigens by tissue transglutaminase on humoral islet autoimmunity in type 1 diabetes
Background: Post-translational modification (PTM) of antigens plays a role in the pathogenesis of many autoimmune disorders. In coeliac disease (CD), tissue transglutaminase (tTG) deamidates gliadin peptides to activate the immune response against the gut endomysium. CD is six times more prevalent i...
Main Authors: | Catherine Donnelly, Alistair Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Metabolism Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589936820300426 |
Similar Items
-
The study of transglutaminase in pancreatic islets
by: Smethurst, Peter Alexander
Published: (1994) -
Analysis of humoral and cellular responses to islet cell antigens in type I diabetes
by: Hawkes, Charlotte Joanne
Published: (1998) -
Humoral immunoreactivity to gliadin and to tissue transglutaminase is present in some patients with multiple myeloma
by: Matkovic Suzana, et al.
Published: (2008-05-01) -
Regulation of T-Cell Signaling by Post-Translational Modifications in Autoimmune Disease
by: Taku Kuwabara, et al.
Published: (2018-03-01) -
Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases
by: Brent J. Ryan, et al.
Published: (2014-01-01)